Log in or Sign up for Free to view tailored content for your specialty!
Biologics News
ACR asks for FDA guidelines on biosimilar substitution
During a public meeting on the reauthorization of the Biosimilar User Free Act, Angus Worthing, MD, FACR, FACP, incoming chair of the American College of Rheumatology’s Governance Affairs Committee, asked the FDA to create guidelines for biosimilar substitution.
Addition of diacerein to glucosamine therapy did not improve outcomes for OA
In a study of 148 patients with mild to moderate osteoarthritis of the knee, combination therapy of glucosamine plus diacerein did not improve pain scores compared with glucosamine monotherapy.
Log in or Sign up for Free to view tailored content for your specialty!
Isto and Arteriocyte form new biologics company
Isto Holdings, the parent company of Isto Technologies, announced it has acquired Arteriocyte Medical Systems Inc. and will integrate the companies under the name Isto Biologics.
Arthroscopic rotator cuff repair augmented with collagen implant had biocompatibility at 6 months
Patients who underwent arthroscopic rotator cuff repair augmented with a collagen implant overlay had cellular incorporation, tissue formation and maturation, implant resorption and biocompatibility at 6-month follow-up, according to results.
Bone marrow concentrate injections considered safe treatment of orthopedic injuries
Patients who received bone marrow concentrate injections alone experienced the lowest rate of adverse events, according to study results.
Speaker: Adjuvants may help resolve nonunions after failed bone grafting
BELFAST, NORTHERN IRELAND — A presenter at the British Orthopaedic Association Annual Congress, here, said orthopaedic surgeons should familiarize themselves with adjuvant treatment options for nonunions, because this is an increasingly challenging problem.
Both local PRP and corticosteroid injections found effective for chronic plantar fasciitis
Patients with chronic plantar fasciitis can be effectively treated with local injection of platelet-rich plasma or corticosteroid, according to results.
Bone Solutions Inc receives $1.7 million in funding
Bone Solutions Inc. announced it has surpassed its goal by achieving a funding round totaling more than $1.7 million after officially closing its private placement memorandum of $1.5 million. The company also reported an additional $1.6 million in committed funding from Next Health LLC.
Tecres and Keensight partner to create Demetra Holding, an independent cement and biomaterials company
Tecres, a medical technology company that develops bone cements and bone substitutes, and Keensight Capital, a European growth private equity firm, recently announced an investment in Demetra Holding.
Triage, teamwork lessons learned from earthquakes, tsunamis and terrorist attacks
Within minutes or days of a mass trauma event, hundreds — possibly thousands — of patients may arrive at the emergency room of a hospital nearest the site of the incident. At these times, orthopaedic surgeons can play a key role in the triage and treatment of patients. Later, when these patients undergo limb salvage, reconstruction or amputation procedures, these physicians typically perform the surgery or are involved in the ongoing management of patients.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read